TL;DR
Get health and wellness essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
Med-El has launched the TICI Unico, which the company describes as the world’s only totally invisible cochlear implant. The device sits entirely under the skin, including its microphone, with no external hardware during everyday use, and follows feasibility studies and early European surgeries.
Med-El has commercially launched the TICI Unico, a totally implantable cochlear implant that the Austrian company describes as the world’s only totally invisible cochlear implant. The device, reported by The Hearing Review, is designed to work entirely beneath the skin — including its microphone — with no external sound processor or other visible hardware during everyday use. The launch follows years of development, feasibility study results, and early surgeries in Europe, and marks the arrival of the first product in a category the hearing healthcare industry has pursued for years: fully implantable hearing restoration.
The TICI Unico is a totally implantable cochlear implant (TICI) that functions entirely subcutaneously, according to Med-El. Unlike conventional cochlear implants, which require an external sound processor worn behind the ear or on the head, the TICI Unico places all working components — including the microphone — under the skin. The company says the device works 24/7, including while sleeping, showering, and swimming, and is not affected by water because it is implanted beneath the skin.
The launch follows promising feasibility study results for Med-El’s TICI platform and early surgeries conducted in Europe, according to The Hearing Review. The TICI Unico is the commercial product resulting from that research and clinical work. Med-El positions the device for patients who prioritize discretion and convenience alongside hearing performance.
The launch adds to a period of activity for the Innsbruck, Austria-based manufacturer, which recently acquired two gene therapy programs from Rescue Hearing and expanded its device connectivity portfolio through a collaboration with Starkey on bimodal Bluetooth. Med-El is privately held and develops cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implants.
Impact on Cochlear Implant Adoption
The launch addresses what the industry has long described as a landmark goal: hearing restoration through a device imperceptible to others. Visible external hardware has been cited as a barrier to cochlear implant uptake, and Med-El CEO Ingeborg Hochmair said she hopes the device “will open the door to hearing for many more people than currently are interested in cochlear implants.”
The development also arrives amid intensified industry-wide efforts to build fully and totally implantable cochlear implants, with multiple manufacturers exploring designs that eliminate external components. Med-El’s device now enters the market as the company’s first-mover answer to that demand — though, per The Hearing Review’s framing, the claims of uniqueness and market position come from the company itself.
For patients, the practical appeal is around-the-clock use: the device is designed to keep working during sleep, showering, and swimming — situations where conventional external processors typically must be removed.
From Feasibility Studies to Market
The TICI Unico is the result of a development program that has been closely tracked by the hearing healthcare industry over several years, according to The Hearing Review. Med-El previously reported promising feasibility study results for the TICI platform and conducted early surgeries with the technology in Europe before arriving at the commercial product.
Med-El, headquartered in Innsbruck, Austria, has been a long-standing player in implantable hearing technology. Co-founder and CEO Ingeborg Hochmair has led the company’s cochlear implant innovation for decades. Recent moves beyond the TICI launch include the acquisition of two gene therapy programs from Rescue Hearing and a connectivity collaboration with Starkey on bimodal Bluetooth.
“TICI Unico is a new category of an implant. It is totally new and it is the realization of a dream that I have had for a very long time.”
— Ingeborg Hochmair, Med-El co-founder and CEO
Questions Left Open by the Launch
Key details were not specified in the announcement as reported. These include pricing, the timeline and scope of market availability by country, regulatory status in specific jurisdictions such as the United States, and patient eligibility criteria. The Hearing Review reported promising feasibility results and early European surgeries, but detailed clinical outcome data for the commercial device was not included.
Claims that the device is the world’s only totally invisible cochlear implant and first to market are Med-El’s own characterizations. Real-world durability, battery life, charging routines, and hearing performance compared with conventional external-processor implants remain to be independently documented as the device reaches patients.
Rollout and Clinical Evidence Ahead
Watch for rollout details as Med-El publishes market-by-market availability and pricing through medel.com and clinical channels. Independent data from early recipients — including speech perception outcomes, battery and charging experience, and device reliability over time — will indicate how the TICI platform performs outside feasibility studies.
Competitor responses are also likely: the industry-wide push toward fully implantable designs has intensified, and other manufacturers are expected to advance their own external-component-free systems. Med-El’s parallel work in gene therapy and bimodal Bluetooth connectivity with Starkey suggests further product announcements ahead.
Key Questions
What makes the TICI Unico different from a conventional cochlear implant?
Conventional cochlear implants require an external sound processor worn behind the ear or on the head. The TICI Unico is designed to function entirely under the skin, including the microphone, with no external hardware during everyday use, according to Med-El.
Can the TICI Unico be used while swimming or showering?
Yes, according to Med-El. Because all components are implanted beneath the skin, the company says the device is not affected by water and works 24/7, including while sleeping, showering, and swimming.
Is the TICI Unico available worldwide?
That is not yet clear. The announcement follows feasibility studies and early surgeries in Europe, but Med-El has not detailed country-by-country availability, pricing, or regulatory status in specific markets such as the United States.
Is it really the only totally invisible cochlear implant?
That is Med-El’s own description. Multiple manufacturers are exploring fully implantable designs, and independent confirmation of the device’s market position and performance is still pending.
Who might benefit from the TICI Unico?
Med-El positions the device for patients who prioritize discretion and convenience alongside hearing performance, and for whom around-the-clock operation matters. Patient eligibility criteria have not been fully detailed.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
